| Date | Title | Description |
| 26.03.2024 |
Corteria Pharmaceuticals announces initiation of Phase 1 s... | Corteria Pharmaceuticals (‘Corteria’), a clinical-stage biopharmaceutical company focused on the dev... |
| 20.03.2024 |
Mainstay Medical Announces Publication of the First Neurom... | Groundbreaking ReActiv8-B study supports the long-term efficacy, safety and durability of ReActiv8® ... |
| 13.03.2024 |
Mainstay Medical Announces Publication of Clinical Results... | Efficacy of ReActiv8® Restorative Neurostimulation™ shows no statistically or clinically meaningful ... |
| 26.02.2024 |
Mainstay Medical Announces US$125 Million Equity Financing... | Funding to accelerate commercial growth and expand clinical and health economic evidence for ReActiv... |
| 21.02.2024 |
MMI Raises $110 Million in Series C Financing | Largest ever investment in microsurgery will further MMI’s mission to transform open surgery with ro... |
| 13.02.2024 |
Mainstay Medical Announces Receipt of FDA Approval for MRI... | U.S. patients implanted with ReActiv8 now eligible for full-body MRI scans
Mainstay Medical Holdi... |
| 08.01.2024 |
Calypso Enters into Agreement to Be Acquired by Novartis | Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by devel... |
| 08.01.2024 |
Inotrem Successfully Reaches Agreement with the FDA for a ... | Novel biomarker-guided Phase 3 registration trial in septic shock with an enrichment strategy-based ... |
| 06.01.2024 |
Corteria Pharmaceuticals appoints Mark Pruzanski as Chairm... | Corteria Pharmaceuticals (“Corteria”), a biopharmaceutical company specialized in the development of... |
| 27.11.2023 |
US FDA grants Orphan Drug Designation to mocravimod to imp... | Mocravimod is the only S1P receptor modulator being developed as an adjunctive and maintenance treat... |
| 14.11.2023 |
Vivasure Medical Announces 100th Patient Enrolled in U.S. ... | PATCH Clinical Study will evaluate the safety and efficacy of Vivasure’s PerQseal Closure Device Sys... |
| 13.11.2023 |
Neurent Medical Announces New CPT Code® for Chronic Rhinit... | CMS Assignment Empowers ENT Physicians and Offers Relief to Millions of Chronic Rhinitis Patients
... |
| 19.10.2023 |
MMI Expands Global Footprint with Entry into Asia Pacific ... | Partnerships with Device Technologies and TRM Korea will strengthen Symani® Surgical System’s entran... |
| 26.09.2023 |
MMI’s Symani® Robotic Surgical System Surpasses 500 Clinic... | Milestone case performed at HUS Helsinki University Hospital demonstrates MMI’s continued momentum i... |
| 07.09.2023 |
Corteria Pharmaceuticals Announces a €65M Financing to Adv... | Corteria Pharmaceuticals (“Corteria”), a biopharmaceutical company specialized in the development of... |
| 29.08.2023 |
Mainstay Medical Announces Completion of Enrollment of RES... | Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative Neu... |
| 25.08.2023 |
XyloCor Therapeutics Presents Phase 2 Data Highlighting Sa... | Positive Phase 2 EXACT Trial results at 6-months underscore significant potential of investigational... |
| 03.08.2023 |
Results from XyloCor Therapeutics’ Phase 1 Portion of EXAC... | Findings from the Phase 1 dose escalation portion of the EXACT trial of XC001 in refractory angina p... |
| 21.07.2023 |
Mainstay Medical Announces Publication of Three-Year Clini... | Further real-world evidence supporting the efficacy and use of ReActiv8® Restorative Neurostimulatio... |
| 18.07.2023 |
XyloCor Therapeutics Reports Sustained Results in 12- Mont... | XC001 demonstrated durable improvements across multiple efficacy measures 12 months after treatment,... |
| 01.06.2023 |
Inotrem Announces Publication of Two Key Articles on Nangi... | Data of ASTONISH Phase 2 trial in septic shock patients is published in The Lancet Respiratory Medic... |
| 15.05.2023 |
Dualyx raises €40 million to progress Treg therapies for a... | Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeti... |
| 14.04.2023 |
Neuromod Devices Closes €30 Million Financing to Expand Av... | Equity investment led by Panakès Partners with venture debt provided by European Investment Bank
Fi... |
| 21.03.2023 |
New Data show NEUROMARK® Chronic Rhinitis Treatment Offers... | Results from the CLARITY Study Show the NEUROMARK® System Provides Safe and Effective Treatment for ... |
| 13.03.2023 |
Vivasure Medical Announces FDA IDE Approval to Initiate U.... | Pivotal study expected to be completed by year-end 2023 and set the stage for commercialization of P... |
| 07.03.2023 |
FDA Grants Lenire® Tinnitus Treatment Device De Novo Appro... | Neuromod Devices' non-invasive device, Lenire, is the first of its kind granted approval to treat ti... |
| 03.02.2023 |
Neurent Medical Announces Limited Market Release of NEUROM... | NEUROMARK received new Category I CPT code and support from AAO position statement
Neurent Medica... |
| 26.01.2023 |
XyloCor Therapeutics Reports Positive Topline Safety and E... | No serious adverse events related to drug product were reported
Patients demonstrated improvements ... |
| 23.01.2023 |
Priothera announces first patients enrolled in pivotal MO-... | Mocravimod is the only S1PR modulator being developed to treat blood cancers and improve CAR-T thera... |
| 09.01.2023 |
Inotrem Receives Funding from the Crohn’s & Colitis Fo... | The funding will support the development of INO-02 a new long-acting therapeutic approach to modulat... |
| 16.12.2022 |
Calypso Biotech Announces First Patient with Eosinophilic ... | Healthy volunteers phase completed showing differentiating target engagement biomarker data and favo... |
| 25.10.2022 |
Inotrem Announces That Its ESSENTIAL Phase II Study for th... |
Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and ... |
| 21.10.2022 |
Corteria Pharmaceuticals strengthens its Executive Leaders... | Corteria Pharmaceuticals, a biotechnology company developing innovative treatments for certain forms... |
| 13.10.2022 |
Inotrem announces the outcome of its Phase II ASTONISH tri... |
Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and ... |
| 30.09.2022 |
Mainstay Medical Announces Publication of Three-Year Patie... |
Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes d... |
| 23.09.2022 |
United Kingdom National Institute for Health and Care Exce... | Mainstay Medical Holdings plc announced today that the National Institute for Health and Care Excell... |
| 20.07.2022 |
Medical Microinstruments Secures $75M to Advance Robotic M... |
Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes ... |
| 30.06.2022 |
Ermium Therapeutics extends its initial €6.3 M funding to ... | Ermium Therapeutics, a Paris-based biotech company developing innovative health products for auto-im... |
| 28.06.2022 |
XyloCor Therapeutics Achieves Target Enrollment in Phase 2... |
XyloCor Therapeutics, a clinical-stage biopharmaceutical company developing novel gene therapies f... |
| 13.06.2022 |
Clinical Mocravimod Data in Hematological Malignancies Pat... |
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P recep... |
| 01.06.2022 |
Priothera Receives Fast Track Designation for mocravimod i... | Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P recepto... |
| 31.05.2022 |
Inotrem announce the appointment of Luke Beshar as Chairma... | Inotrem, an advanced clinical stage biotech company developing TREM- 1 targeting immunotherapies for... |
| 26.05.2022 |
Medical Microinstruments Launches New Simulator for Roboti... |
Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes fo... |
| 18.05.2022 |
Medical Microinstruments Announces Major Expansion in Pisa... |
Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes fo... |
| 18.05.2022 |
XyloCor Therapeutics Announces Presentation of Preliminary... |
XyloCor Therapeutics, a clinical‑stage biopharmaceutical company developing novel gene therapies f... |
| 17.05.2022 |
Vivasure Medical Announces Series D Financing to Advance P... |
Vivasure Medical® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable techn... |
| 25.04.2022 |
Priothera Receives FDA clearance of IND to start Phase 2b/... |
Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P r... |
| 20.04.2022 |
Vivasure Medical Begins Clinical Evaluation of Next-Genera... | Vivasure Medical® today announced the first patient was enrolled in the Frontier V study, a European... |
| 14.04.2022 |
Inotrem and the Crohn’s & Colitis Foundation Sign a R&... |
Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... |
| 12.04.2022 |
Priothera Receives First Regulatory Approvals to Start a G... |
Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P r... |
| 06.04.2022 |
Neuromod establishes global commercial leadership team |
Neuromod Devices Ltd. has announced the formation of a global commercial leadership team to direct... |
| 04.03.2022 |
Priothera – FDA and EMA Grant Orphan Drug Designation to m... |
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P recep... |
| 01.03.2022 |
AbbVie Acquires Syndesi Therapeutics, Strengthening Neuros... |
AbbVie (NYSE: ABBV) today announced it has completed the acquisition of Syndesi Therapeutics SA, w... |
| 23.02.2022 |
Priothera Enters Loan Agreement of €17.5 Million with the ... |
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P recep... |
| 18.01.2022 |
XyloCor Therapeutics Expands Leadership Team with Accompli... |
XyloCor Therapeutics, a clinical‑stage biopharmaceutical company developing novel gene therapies f... |
| 14.01.2022 |
Neuromod launches Ótologie to provide specialist care serv... | Irish medical device company, Neuromod Devices Ltd, has launched Ótologie, a specialist healthcare s... |
| 07.01.2022 |
Mainstay Medical Announces Publication of Two-Year Patient... |
Mainstay Medical Holdings plc today announced the publication of the two-year patient outcomes dat... |
| 14.12.2021 |
Mainstay Medical Announces Appointment of Jeffrey Dunn and... | Mainstay Medical Holdings plc today announced the appointment of two new independent members to the ... |
| 25.11.2021 |
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medi... | Priothera Limited, a late-clinical stage biotechnology company pioneering the development of its S1P... |
| 18.11.2021 |
Neurent Medical Receives FDA Clearance for NEUROMARK™, a N... |
Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal di... |
| 09.11.2021 |
Inotrem appoints Dr. Gregory Meiffren as Project Director ... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies targeting the TRE... |
| 27.10.2021 |
Neuromod appoints Teri Minard to lead introduction of tinn... | Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, ... |
| 21.10.2021 |
Syndesi Therapeutics announces commencement of dosing in c... | Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the s... |
| 13.09.2021 |
Neuromod appoints Eric Timm as US Chief Executive Officer | Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, ... |
| 09.09.2021 |
Calypso Biotech announces first patient with Celiac Diseas... |
Calypso Biotech, a leader in the development of Interleukin-15 (IL-15) targeted therapies, announc... |
| 26.08.2021 |
Neuromod Establishes U.S. Presence, Adds Local Leadership | Neuromod Devices Ltd, the Irish medical device company specialising in the treatment of tinnitus, ha... |
| 16.08.2021 |
Neuromod appoints US hearing aid industry expert and audio... | Neuromod Devices Ltd, the Irish medical device company, has announced the appointment of Ms. Susan W... |
| 10.08.2021 |
Lymphovenous Anastomosis and Lymph Node Transfer Performed... |
Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes fo... |
| 27.07.2021 |
XyloCor Therapeutics Commences Phase 2 Component of Phase ... | XyloCor Therapeutics, a clinical-stage biopharmaceutical company developing novel gene therapies for... |
| 22.07.2021 |
Medical Microinstruments Announces First Commercial Instal... |
Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes fo... |
| 15.07.2021 |
Vivasure Medical Announces Development of Sutureless Venou... |
Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel ... |
| 13.07.2021 |
Neuromod research reveals that more than three in four UK ... | New research from Irish medical device company, Neuromod Devices Ltd, has found that more than three... |
| 13.07.2021 |
Medical Microinstruments’ Symani Surgical System Saves Pat... | Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for ... |
| 12.07.2021 |
Inotrem Receives Approval to Expand Nangibotide Clinical T... |
Inotrem S.A., a biotechnology company specializing in the development of immunotherapies targeting... |
| 07.07.2021 |
NeRRe Therapeutics raises £20 million in a Series B2 finan... | NeRRe Therapeutics, a clinical-stage company developing orvepitant, its wholly-owned neurokinin-1 (N... |
| 30.06.2021 |
Mainstay Medical Announces Limited Commercial Launch of Re... |
Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the... |
| 29.06.2021 |
Neurent Medical Expands Leadership Team to Support Advance... |
Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal di... |
| 23.06.2021 |
Inotrem adds a new strategic asset to its immunotherapy an... |
Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... |
| 10.06.2021 |
Inotrem announces positive outcome of interim futility ana... |
Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... |
| 20.04.2021 |
Vivasure Medical Begins Clinical Evaluation of Next-Genera... | Vivasure Medical® today announced the first patient was enrolled in the Frontier V study, a European... |
| 24.03.2021 |
Inotrem bolsters leadership team with the appointment of S... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chr... |
| 22.03.2021 |
XyloCor Therapeutics Completes Oversubscribed $41.9 Millio... |
XyloCor Therapeutics, a private clinical-stage biopharmaceutical company focused on the developmen... |
| 11.03.2021 | Uzmanību!
Внимание! | - |
| 09.03.2021 |
Mainstay Medical Announces Commercial Launch of ReActiv8® ... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the commercial launch in... |
| 16.02.2021 |
Mainstay Medical Announces US$108 Million Equity Financing... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity... |
| 27.01.2021 |
Syndesi Therapeutics Announces Positive Results From Two A... | Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the s... |
| 26.01.2021 |
Mainstay Medical Announces Key Strategic Hires to Drive Gl... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced recent senior leadership... |
| 20.01.2021 |
Neurent Medical Closes $25 Million Series B Funding to Adv... |
Galway, Ireland – Neurent Medical, a company pioneering innovative treatments for chronic inflamma... |
| 12.01.2021 |
Medical Microinstruments Appoints Healthcare Industry Vete... | CALCI, Italy – Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinica... |
| 21.12.2020 |
Inotrem announces Data Monitoring Committee (DMC) recommen... | Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting th... |
| 02.11.2020 |
Fountain Healthcare Partners Announces Final Close of €125... |
Fountain Healthcare Partners (“Fountain”) today announces the Final Closing of its third fund, Fou... |
| 28.10.2020 |
MMI SpA Launches Breakthrough Technology, Advancing Roboti... | MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsu... |
| 20.10.2020 |
Neuromod Successfully Closes €10.5 Million Series B Financ... | Proceeds to accelerate ongoing European commercialisation, scale-up manufacturing capacity, advance ... |
| 12.10.2020 |
Priothera closes €30 million Series A financing to develop... | Priothera Limited, a clinical stage company developing orally applied sphingosine 1 phosphate (S1P) ... |
| 08.10.2020 |
Neuromod Publishes Results of Large-Scale Tinnitus Clinica... |
Neuromod Devices Limited (“Neuromod”), the Irish medical device company specialising in the treatm... |
| 28.09.2020 |
Inotrem expands its Leadership Team with the appointment D... | Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting th... |
| 28.09.2020 |
Syndesi Therapeutics progresses development of SDI-118 for... | Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the s... |
| 21.09.2020 |
Inflazome announces acquisition by Roche |
Dublin (IE), Cambridge (UK): Inflazome announced today that it has closed a share purchase agreeme... |
| 11.08.2020 |
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd. | Bayer, a global leader in women’s healthcare, and KaNDy Therapeutics Ltd, a UK clinical-stage biotec... |
| 23.07.2020 |
Inotrem receives clearance from French, Belgian and US aut... |
Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting ... |